BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7508947)

  • 1. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer.
    Karasik A; Menczer J; Pariente C; Kanety H
    J Clin Endocrinol Metab; 1994 Feb; 78(2):271-6. PubMed ID: 7508947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid.
    Kanety H; Kattan M; Goldberg I; Kopolovic J; Ravia J; Menczer J; Karasik A
    Br J Cancer; 1996 May; 73(9):1069-73. PubMed ID: 8624265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IGF system in the neonatal ovine uterus.
    Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
    Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in insulin-like growth factor I, 17-b-estradiol, and progesterone in postmenopausal women with benign and malignant ovarian tumours.
    Waksmański B; Dudkiewicz J; Kowalski T
    Med Sci Monit; 2001; 7(5):919-23. PubMed ID: 11535935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis.
    Giudice LC; Dsupin BA; Gargosky SE; Rosenfeld RG; Irwin JC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1284-93. PubMed ID: 7525631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1.
    Hurley MM; Abreu C; Hakeda Y
    J Bone Miner Res; 1995 Feb; 10(2):222-30. PubMed ID: 7538725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expressions and clinical significance of IGFBP-2, -3 in both serum and tumor tissues in patients with epithelial ovarian cancer].
    Yan XJ; Tian Y; Wang C; Wang XL; Di JM; Cheng JX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):639-43. PubMed ID: 19764562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1.
    Hembree JR; Agarwal C; Eckert RL
    Cancer Res; 1994 Jun; 54(12):3160-6. PubMed ID: 7515765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen.
    Krywicki RF; Figueroa JA; Jackson JG; Kozelsky TW; Shimasaki S; Von Hoff DD; Yee D
    Eur J Cancer; 1993; 29A(14):2015-9. PubMed ID: 7506561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polycystic and multicystic ovaries.
    Holly JM; Eden JA; Alaghband-Zadeh J; Carter GD; Jemmott RC; Cianfarani S; Chard T; Wass JA
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):53-64. PubMed ID: 1698131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor.
    Flyvbjerg A; Mogensen O; Mogensen B; Nielsen OS
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2308-13. PubMed ID: 9215312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
    Bang P; Brismar K; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome.
    Cataldo NA; Giudice LC
    J Clin Endocrinol Metab; 1992 Mar; 74(3):695-7. PubMed ID: 1371292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in porcine serum during fetal and postnatal development.
    Lee CY; Bazer FW; Etherton TD; Simmen FA
    Endocrinology; 1991 May; 128(5):2336-44. PubMed ID: 1708333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.